A critical discovery in cancer study is emerging with the use of nanobodies to re-engage damaged p53. This crucial tumor suppressor protein is frequently inactivated in several types of malignancies, resulting https://minibookmarks.com/story21898370/vhh-fragments-revive-p53-a-potential-approach-for-cancer-therapy